Controlled Substance Discrepancies and Morphine Documentation Errors
Summary
The facility failed to provide pharmaceutical services in accordance with professional standards by not ensuring a system was in place to document and resolve controlled substance discrepancies for Ambien, Klonopin, Percocet, and Ultram stored in the Automated Dispensing System (ADS). A discrepancy report initially provided to the surveyor listed these medications but did not include dates or resident names. When a dated report was later obtained, it showed multiple discrepancies, including minus and plus counts for the same controlled medications over several dates. The DON stated the discrepancies were due to nurses misunderstanding how to enter counts into the machine and described them as clerical errors. The DON told the surveyor that she had spoken with the nurses involved, reviewed which resident each medication had been dispensed for, and provided education, but the surveyor requested records of the individual education and investigations to rule out diversion. The facility’s policy stated that the DNS shall investigate narcotics reconciliation discrepancies to determine the cause and identify responsible parties and provide a written report to the Administrator. When the survey team requested documentation, the DON later provided investigations for some of the discrepancies, but the Percocet documentation did not include a written conclusion. The consultant pharmacist stated he was unaware of the controlled substance discrepancies and had not been notified of them. The facility also failed to accurately account for and document the administration of a controlled medication, liquid morphine sulfate, on one medication cart. During a medication storage audit, surveyors observed a bottle of morphine sulfate liquid that appeared to have been opened, but the resident’s controlled drug record showed the medication had never been given to the resident for whom it was prescribed. When the bottle was opened in the presence of staff and surveyors, a silver-colored foil seal was observed under the cap, indicating the bottle had been sealed. Staff stated that if the declining sheet was blank, the medication had not been given and should not be opened, and that controlled medications were counted against the declining sheet at the beginning and end of each shift. The bottle and box had no date indicating when it had been opened.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.